Biomedical literature, made navigable
Discover articles through diseases, drugs, treatments, interventions, clinical instruments, institutions and funders extracted from the BMJ open corpus.
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsChoose an entity to see the articles in which it was identified.
… cases, 48,1%) and peripheral vasodilators (five cases, 20,8%). Acetylcysteine was the most commonly used mucolytic (11 cases). Other LTVD cat…
…–5 years from symptom onset. Antifibrotic agents–nintedanib and pirfenidone–slow disease progression and may extend survival. However, real…
…e its potential impact in patients with breast cancer receiving sacituzumab govitecan.Material and Methods We conducted a retrospective study in two …
…ction and improved clinical status in a patient with refractory hypothyroidism. Although not included in current clinical guidelines, this app…
… 5% had ovarian, renal or lung cancer. The involved drugs were: enzalutamide(25), apalutamide(14), abiraterone (9), abemaciclib(6), capecita…
…of amitriptyline, flunarizine, topiramate, and botulinum toxin, atogepant 60 mg daily was initiated in August 2024. Three months later, m…
…ble strategy for prioritising interventions aimed at optimising pharmacotherapy and preventing further visits due to ADEs.Aim and Objectives To…
… a tapering regimen at 1 mg/Kg/day), tocilizumab (8 mg/kg), and anakinra (200 mg/day). The clinical pharmacist followed the patient thro…
…n areas of ENBP reported to have highly variable DTP1, DTP3 and measles-rubella first-dose (MR1) coverage.Methods Qualitative in-depth semi-str…
…cular aneurysms arising from distal parent vessels treated with p48 MW HPC.Methods We conducted a multicenter, retrospective cohort study …
…n excellent outcome in mild stroke. Over 40% of patients with a mild stroke treated with BMM experienced END, and rEVT effectively improved…
…t 12–25 weeks’ gestation, with subclinical to moderate clinical Edinburgh Postnatal Depression Scale (EPDS) scores: 9–16. Exclusion criteria were psychosis and self…